|

HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform

RECRUITINGN/ASponsored by Universitätsklinikum Hamburg-Eppendorf
Actively Recruiting
PhaseN/A
SponsorUniversitätsklinikum Hamburg-Eppendorf
Started2026-06-04
Est. completion2027-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Severe obesity is a chronic condition that can lead to a range of serious health problems. One common treatment option is sleeve gastrectomy, a weight-loss operation in which the size of the stomach is reduced. These procedures are increasingly being performed with the support of robotic surgical systems. However, there is still limited clinical experience with the Hugo™ Robotic-Assisted Surgery System for this type of operation. The aim of this study is to evaluate whether sleeve gastrectomy can be performed safely and reliably using the Hugo™ system. In particular, the study will assess whether the operation can be completed as planned with the robotic system and will examine outcomes during and after surgery. The study will include 50 adults with severe obesity who are scheduled to undergo sleeve gastrectomy. Information will be collected during the operation, including the duration of different surgical steps and the occurrence of any complications. Participants will be followed for six months after surgery. During this period, information on pain, complications, hospital stays, readmissions, and quality of life will be collected. The study aims to provide important information about the safe introduction and use of the Hugo™ system for this established weight-loss procedure.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 years
* Body mass index (BMI) ≥ 40 kg/m², or BMI ≥ 35 kg/m² in the presence of at least one obesity-related comorbidity
* Scheduled for elective primary sleeve gastrectomy
* Ability to provide written informed consent
* Sufficient language proficiency to participate in the study.

Exclusion Criteria:

* Previous upper abdominal surgery
* Revisional bariatric surgery
* American Society of Anesthesiologists (ASA) physical status classification ≥ IV
* Oral anticoagulation therapy
* Presence of a ventriculoperitoneal shunt
* Severe hepatomegaly or other contraindications to a robotic surgical approach

Conditions5

DiabetesObesity (BMI > 35)Obesity (BMI > 35) and Diabetes MellitusObesity (BMI > 35) and DyslipemiaObesity (BMI > 35) and High Blood Pressure

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.